Literature DB >> 12243806

Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.

Pehr A Lind1, Lawrence B Marks, Donna Hollis, Ming Fan, Su-Min Zhou, Michael T Munley, Timothy D Shafman, Ronald J Jaszczak, R Edward Coleman.   

Abstract

PURPOSE: To assess the utility of dosimetric/functional metrics as predictors of symptomatic radiation pneumonitis using receiver operating characteristic curves.
METHODS: Between 1991 and 1999, 277 patients were enrolled on a prospective clinical study to relate radiation therapy (RT) induced changes in lung function with dosimetric and functional metrics. Pre-RT whole and regional functional assessments included pulmonary function tests and single photon emission computed tomography lung perfusion scans. Patients had three-dimensional planning scans and dose calculations (reflecting tissue density heterogeneity) to provide a dose-volume histogram of the lung and associated dosimetric parameters (MLD = mean lung dose, V30 = % of lung receiving >or=30 Gy). Fusion of single photon emission computed tomography and computed tomography scans provides perfusion-weighted dose-function histograms and associated dosimetric parameters (mean perfusion-weighted lung dose). The incidence of clinically relevant radiation pneumonitis requiring steroids was related to the dosimetric and functional metrics. The predictive abilities of models (sensitivity and specificity) were calculated and compared based on the area beneath receiver operating characteristic (ROC) curves (Wilcoxon rank-sum and chi-square).
RESULTS: Twenty-seven of 162 evaluable patients with >or=6 months' follow-up developed pneumonitis requiring steroids. Single metrics were typically not good predictors for pneumonitis ( area under ROC curve = 0.5-0.68). The two-dimensional models (e.g., MLD and pre-RT diffusion capacity for carbon monoxide) generally provided greater ROC areas (0.61-0.72). Overall, the models that considered a measure of pre-RT lung function (i.e., pulmonary function tests), the MLD, and mean perfusion-weighted lung dose were best correlated with outcome (ROC area: 0.7) (p < 0.05 compared to unidimensional models). However, because the area under the ROC curve for these models was <<1, they too seemed not to be ideal.
CONCLUSION: Predicting symptomatic radiation pneumonitis remains difficult. Multiparameter models that consider pre-RT pulmonary function and the three-dimensional dose distribution seem to be best able to predict outcome. Additional studies are needed to better understand the dosimetric/functional determinants of radiation pneumonitis.

Entities:  

Mesh:

Year:  2002        PMID: 12243806     DOI: 10.1016/s0360-3016(02)02932-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  27 in total

1.  Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer.

Authors:  Mehmet Kiliç; Erdal Göçmen; Mesut Tez; Tamer Ertan; Mehmet Keskek; Mahmut Koç
Journal:  Can J Surg       Date:  2006-08       Impact factor: 2.089

2.  Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.

Authors:  An-Na Tong; Peng Yan; Guang-Hui Yuan; Xiao-Yan Lv; Hai Gong; Hui Zhao; Yan-Ming Wang
Journal:  Mol Clin Oncol       Date:  2014-12-10

3.  Dose-volume histogram parameters for predicting radiation pneumonitis using receiver operating characteristic curve.

Authors:  Dongqing Wang; Jian Shi; Shaohua Liang; Shiyong Lu; Xiangjie Qi; Qiang Wang; Guojing Zheng; Sheng Wang; Kemin Zhang; Hongfu Liu
Journal:  Clin Transl Oncol       Date:  2012-09-14       Impact factor: 3.405

4.  Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.

Authors:  Austin M Faught; Yuya Miyasaka; Noriyuki Kadoya; Richard Castillo; Edward Castillo; Yevgeniy Vinogradskiy; Tokihiro Yamamoto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-04-26       Impact factor: 7.038

5.  Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis.

Authors:  Zafer Kocak; Gerben R Borst; Jing Zeng; Sumin Zhou; Donna R Hollis; Junan Zhang; Elizabeth S Evans; Rodney J Folz; Terrence Wong; Daniel Kahn; Jose S A Belderbos; Joos V Lebesque; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-01       Impact factor: 7.038

6.  Challenges scoring radiation pneumonitis in patients irradiated for lung cancer.

Authors:  Eda Yirmibesoglu; Daniel S Higginson; Merdan Fayda; M Patricia Rivera; Jan Halle; Julian Rosenman; Liyi Xie; Lawrence B Marks
Journal:  Lung Cancer       Date:  2012-01-09       Impact factor: 5.705

7.  Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.

Authors:  Gurleen Dhami; Jing Zeng; Hubert J Vesselle; Paul E Kinahan; Robert S Miyaoka; Shilpen A Patel; Ramesh Rengan; Stephen R Bowen
Journal:  Strahlenther Onkol       Date:  2017-03-02       Impact factor: 3.621

Review 8.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.

Authors:  Matthew J Krasin; Louis S Constine; Debra L Friedman; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

9.  Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy.

Authors:  Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-10-18       Impact factor: 7.038

10.  Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.

Authors:  Yevgeniy Vinogradskiy; Richard Castillo; Edward Castillo; Susan L Tucker; Zhongxing Liao; Thomas Guerrero; Mary K Martel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-06       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.